Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immunoprecise Antibodies Ltd (IPA)

Immunoprecise Antibodies Ltd (IPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,536
  • Shares Outstanding, K 28,832
  • Annual Sales, $ 18,160 K
  • Annual Income, $ -20,130 K
  • EBIT $ -9 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.06
  • Price/Sales 0.67
  • Price/Cash Flow N/A
  • Price/Book 0.51
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.78
  • Most Recent Earnings $-0.07 on 12/10/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 660.47% ( +205.70%)
  • Historical Volatility 75.12%
  • IV Percentile 94%
  • IV Rank 63.57%
  • IV High 1,002.30% on 01/10/24
  • IV Low 64.04% on 02/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 25
  • Volume Avg (30-Day) 61
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,085
  • Open Int (30-Day) 882

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3248 +23.18%
on 11/21/24
0.4800 -16.65%
on 12/09/24
+0.0142 (+3.68%)
since 11/20/24
3-Month
0.3248 +23.18%
on 11/21/24
0.6950 -42.43%
on 10/25/24
-0.2699 (-40.28%)
since 09/20/24
52-Week
0.3248 +23.18%
on 11/21/24
2.6000 -84.61%
on 02/06/24
-0.9499 (-70.36%)
since 12/20/23

Most Recent Stories

More News
IPA to Present at The Microcap Conference 2025

VICTORIA, BC / ACCESSWIRE / December 19, 2024 / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is...

IPA : 0.4001 (-4.76%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

THAR : 2.07 (-1.43%)
ACXP : 0.8250 (+8.77%)
UBI.AX : 0.110 (-12.00%)
GRF.VN : 0.480 (-4.00%)
WISA : 1.7000 (-1.16%)
NNVC : 1.4900 (+2.76%)
ALCO : 26.17 (+3.60%)
MYPS : 2.12 (+8.72%)
ABL : 7.72 (+2.80%)
PERF : 2.22 (+1.83%)
PETV : 0.4500 (+0.45%)
ABEO : 5.70 (+1.24%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

ESGH.TO : 29.84 (-0.23%)
THAR : 2.07 (-1.43%)
ACXP : 0.8250 (+8.77%)
GRF.VN : 0.480 (-4.00%)
WISA : 1.7000 (-1.16%)
ALCO : 26.17 (+3.60%)
NNVC : 1.4900 (+2.76%)
ABL : 7.72 (+2.80%)
MYPS : 2.12 (+8.72%)
PERF : 2.22 (+1.83%)
PETV : 0.4500 (+0.45%)
ABEO : 5.70 (+1.24%)
Light Week for Macroeconomic Figures in U.S.

Monday U.S. Economic Lookahead Consumer Credit (May) Featured Earnings Greenbrier ...

GBX : 62.35 (+0.34%)
IPA : 0.4001 (-4.76%)
AMX : 14.25 (+0.28%)
HELE : 62.78 (+1.01%)
SGH : 20.85 (+0.43%)
WDFC : 249.94 (-2.95%)
PSMT : 94.00 (+0.07%)
AZZ : 81.66 (+0.11%)
PEP : 152.79 (+0.87%)
PRGS : 66.38 (+0.70%)
CTAS : 186.94 (+2.27%)
JPM : 237.60 (+1.99%)
ImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with Astellas

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”) an AI-driven biotherapeutic research and technology company today announced a research collaboration...

IPA : 0.4001 (-4.76%)
European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), the parent company of BioKey and affiliate of BioStrand, announced today that the EPO has issued a “Decision...

IPA : 0.4001 (-4.76%)
ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival Rates

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, is pleased to announce that its wholly...

IPA : 0.4001 (-4.76%)
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced financial results for third quarter fiscal...

IPA : 0.4001 (-4.76%)
ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, today announced that Talem Therapeutics...

IPA : 0.4001 (-4.76%)
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss...

IPA : 0.4001 (-4.76%)

Business Summary

ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.

See More

Key Turning Points

3rd Resistance Point 0.4683
2nd Resistance Point 0.4542
1st Resistance Point 0.4271
Last Price 0.4001
1st Support Level 0.3859
2nd Support Level 0.3718
3rd Support Level 0.3447

See More

52-Week High 2.6000
Fibonacci 61.8% 1.7309
Fibonacci 50% 1.4624
Fibonacci 38.2% 1.1939
Last Price 0.4001
52-Week Low 0.3248

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar